Every dose, logged in a tap
The time, the amount you took and the injection site, kept in one history you can scroll back through.
Log every Retatrutide dose and injection site, get a reminder when the next one is due, and know when your vials will run out. For LY3437943 too.
Tracking, not advice. PepMe records what you and your prescriber decide. It never suggests a dose.
The time, the amount you took and the injection site, kept in one history you can scroll back through.
Set the days and times for Retatrutide (it’s commonly logged weekly) and get a reminder on your phone, or by email.
PepMe remembers where you went last and suggests the next site on the rotation, so you’re not guessing.
Add your Retatrutide vials and PepMe counts down from your logged doses, with a heads-up before one runs out.
Note nausea, appetite, energy and sleep in the journal, with weight and progress photos alongside.
Add lab results and see them next to what you were taking when they were drawn.
Triple GLP-1 / GIP / glucagon receptor agonist (Eli Lilly, LY3437943). In phase 3 trials for obesity and type 2 diabetes.
Investigational. Phase 3 trials ongoing; not FDA-approved at the time of writing.
Retatrutide reference: half-life, regulatory status and clinical trials →No. PepMe records what you and your prescriber or clinic have decided: the dose, the schedule and when you took it. It never suggests a dose or a change to one.
Yes. Set the days and times (people commonly log Retatrutide weekly) and PepMe sends a reminder to your phone, or an email if you don't have the app on a phone.
Yes. Add your vials and PepMe counts down from the doses you log, shows roughly when they run out, and reminds you to reorder with time for delivery.
If your clinic uses PepMe, you choose exactly what they can see, you can see every time they look, and you can stop sharing at any time.
30 days free, then one subscription with everything in it (see pepme.health/pricing). If you stop paying, everything you logged stays readable and exportable.